THERE IS A TRACE OF DISCOMFORT on Ajay Piramal's face as he sits in a sprawling room on the first floor of his luxurious home in Mumbai's upmarket Worli Sea Face. A speck of dirt on his glasses refuses to go away. He tries to knock it off with his tie, but in vain. Finally, he asks one of his assistants for another pair. Once that sits well, he flashes a broad smile. In many ways, a lot is known about Piramal, yet he remains an enigma. The soft-spoken demeanour conceals the aggression of the feisty businessman. Quite rightly, he has earned the title of the M&A man. The growth story through the 1980s and the period beyond has been characterised by spotting that little nugget in a huge pile and nurturing it. “His buys will surprise you, but the timing of the exit is what justifies the deal,” says someone who has worked closely with him for years.
This version of him is about getting ready for the next battle, driven primarily by pharmaceuticals and financial services. A lot of action is already done through buyouts, but Piramal is looking for more. His holding company, the ₹12,809-crore Piramal Enterprises, houses both the businesses, and a demerger has already been announced to create two entities. One, Piramal Enterprises, which will house financial services (retail and wholesale lending, alternatives, and investments). And two, Piramal Pharma, which will further have four businesses—CDMO (contract development and manufacturing organisation), complex hospital generics, India consumer healthcare, and ophthalmology. The demerger, expected to be completed this year, will be a significant step in a new journey and lay the foundation for version 2.0 of Ajay Piramal.
Strategy time
Esta historia es de la edición May 29, 2022 de Business Today.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición May 29, 2022 de Business Today.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
"Focus on the challenge of each customer"
SHASHANK KUMAR MD & CO-FOUNDER I RAZORPAY Razorpay is India's first full-stack financial solutions company
PEDAL ON THE FUTURE
THE MG WINDSOR EV, WITH ITS FUTURISTIC AND MINIMALIST DESIGN, COMBINES THE BEST OF BOTH WORLDS-COMFORT AND TECHNOLOGY
BREATHE EASY
Whether you're battling allergies, looking to remove pollutants, or simply want to breathe easier, the right air purifier can make a difference
The Taste of India in a Glass
FROM ROYAL LIQUEURS TO DISTILLED MAHUA, INDIAN HERITAGE ALCOHOLIC BEVERAGES ARE HAVING THEIR DAY IN THE SUN
LOOK BEFORE YOU LEAP
IN 2025, INVESTORS WILL NEED TO FACTOR IN VOLATILITY ACROSS ASSET CLASSES
MISSING ADVISORS
INDIA HAS JUST ONE INVESTMENT ADVISOR FOR NEARLY EVERY 200,000 INVESTORS. AT A TIME WHEN RETAIL PARTICIPATION IN THE STOCK MARKETS IS BOOMING, THIS ASSUMES SIGNIFICANCE
TURNING A CORNER
SHARED ELECTRIC MOBILITY START-UP YULU'S SHIFT TO SERVICING THE QUICK COMMERCE SECTOR IS HELPING IT GROW FAST. IT IS NOW FOCUSSING ON IMPROVING ROAD SAFETY FEATURES AS IT TURNS EBITDA POSITIVE
REALITY CHECK
INDIAN STOCK MARKETS PLUNGED BEGINNING OCTOBER FOR A HOST OF REASONS, INCLUDING A FALL IN FII OWNERSHIP. HOW DEEP WILL THE CORRECTION BE?
TRUMP'S TRADE TANGO
The return of Donald Trump as the 47th President of the US has put the global economy on edge. India, too, is unlikely to remain unaffected. How will policymakers meet this latest challenge?
"The essence of the Trump administration will be transactional”
Global investor, analyst, and best-selling author Ruchir Sharma decodes why Donald Trump won the elections, what India should do, the risks, and more